Postscripts Rx
Conversations Beyond the Prescription. Where pharma, HCPs, life science and digital health solutions meets patients—after the script is written. Conversations on digital health, engagement, and real-world impacts that are re-writing the future of patient engagement.
Postscripts Rx
Fierce Pharma Week - Day 1 Expectations
A quick chat with Medisafe's Ryan Janvion, Stacey Wasserman and Cathy Zaremba on what to expect at Fierce Pharma Week 2025. Industry leaders discuss how hyper-personalization sets true patient engagement apart from the buzzwords that saturate the pharmaceutical industry.
• Excitement about sharing Medisafe's new updates with conference attendees
• The significance of behavioral intervention technology in creating effective patient engagement
• How direct-to-consumer experience enables hyper-personalization in healthcare
• Patient engagement becoming a popular concept but with varying levels of implementation
• The importance of building tools that support patients throughout their treatment journey
• 13 years of experience connecting with 13 million patients has created deep expertise
PostScripts Rx is not intended to constitute medical advice, nor is it intended to influence prescribing decisions or any other medical or clinical decision-making. All medical and clinical judgment and decision-making, prescribing decisions, and all related considerations remain exclusively the responsibility of providers and patients.
Good morning. I'm here with Stacey Wasserman. Stacey, how you doing? I'm doing well. We're excited for a good conference. What are you looking forward to most about this conference coming up?
Speaker 2:Well, of course, great to see your friends, colleagues, clients, but I'm also excited to tell people about what's going on at Medisave.
Speaker 1:It's been a lot. A lot of this changed over the last month, or last year, I should say.
Speaker 2:A lot of new stuff, a lot of new things to talk about.
Speaker 1:Yeah, and this is probably the first time where there's thousands of people here, so they combined it all into one conference this year and a lot of people probably the biggest floor I've seen coming to conferences. So a lot of people are going to be stopping by the booth and we're excited to tell them all the new updates that Medisafe has been having when it comes to patient engagement and patient adherence. All right, we are at Fierce Pharma Week. My name is Ryan Jambion. I am here with Kathy Zaremba and we are excited to kick off Fierce Pharma Week 2025, talking a little bit about patient engagement, behavioral intervention technology. Kathy, what are you looking forward to most about the conference coming up?
Speaker 2:Really looking forward to seeing colleagues I haven't seen in a while and hearing what excites them about patient engagement and really learning how they would define behavioral intervention technology. What does that mean to them?
Speaker 1:Huh, what does that mean to you actually?
Speaker 2:Well, actually it is what sets us apart. I really believe that is what gives us our hyper-personalization. That delivers patient engagement that matters, that really delivers. And we're really the only ones that can do that because we have the direct-to-consumer experience.
Speaker 1:It's a trend that's happening a lot in pharma, not only from a pharma marketing perspective. Everyone's trying to figure out how we can get closer to the patient. Ultimately, patient engagement has become a huge buzzword right, everybody's trying to get involved with patient engagement and people can sound a lot very you know the same, it seems like. So we're excited to educate people on how we've been doing this from the get go right, starting with patients and giving them tools to better support themselves across their treatment journey. So it should be a good conference. I'm looking forward to it.
Speaker 2:Me too. We go deep in our experience. 13 years, 13 million patients, it's awesome.
